NDC 50242-333

Herceptin

Trastuzumab

Herceptin is a Kit in the Human Prescription Drug category. It is labeled and distributed by Genentech, Inc.. The primary component is .

Product ID50242-333_23b49e45-e152-40c5-bbc9-be52fce667af
NDC50242-333
Product TypeHuman Prescription Drug
Proprietary NameHerceptin
Generic NameTrastuzumab
Dosage FormKit
Marketing Start Date1998-09-25
Marketing CategoryBLA / BLA
Application NumberBLA103792
Labeler NameGenentech, Inc.
Active Ingredient Strength0
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 50242-333-01

1 KIT in 1 CARTON (50242-333-01) * 20 mL in 1 VIAL, MULTI-DOSE * 20 mL in 1 VIAL
Marketing Start Date1998-09-25
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 50242-333-01 [50242033301]

Herceptin KIT
Marketing CategoryBLA
Application NumberBLA103792
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1998-09-25

Drug Details

OpenFDA Data

SPL SET ID:492dbdb2-077e-4064-bff3-372d6af0a7a2
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1922509
  • 1922518
  • 1922512
  • 1922516
  • 806573
  • 806575
  • NDC Crossover Matching brand name "Herceptin" or generic name "Trastuzumab"

    NDCBrand NameGeneric Name
    50242-132HerceptinTrastuzumab
    50242-134HerceptinTrastuzumab
    50242-333HerceptinTrastuzumab
    63459-303HERZUMATRASTUZUMAB
    63459-305HERZUMATRASTUZUMAB
    67457-845OGIVRItrastuzumab
    67457-847OGIVRItrastuzumab
    67457-991OGIVRItrastuzumab
    0006-5033Ontruzanttrastuzumab
    0069-0305Trazimera-qyyptrastuzumab

    Trademark Results [Herceptin]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    HERCEPTIN
    HERCEPTIN
    74733146 2157198 Live/Registered
    GENENTECH, INC.
    1995-09-22

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.